Introduction
============

The internal globus pallidus (GPi) and substantia nigra pars reticulata (SNr) are the basal ganglia (BG) output nuclei. Besides projecting to the thalamus to form the cortico-BG loops (Chevalier et al., [@B15]; Albin et al., [@B3]; Smith and Bolam, [@B53]; Alexander and Crutcher, [@B4]; DeLong, [@B18]; Smith et al., [@B52]; Haber, [@B27]), output nuclei also project to pons and brain stem to control descending pathways and central patterns generators (CPGs) that regulate muscular tone and automatic or rhythmic motor responses (Takakusaki et al., [@B55], [@B56]; Grillner et al., [@B24]). In birds, reptiles, and lower vertebrates in which the cortex is not well developed, the control of brain stem nuclei is a main function of the BG (Reiner et al., [@B48]; Grillner et al., [@B23], [@B24]; Gale and Perkel, [@B21]). In the SNr, inhibitory postsynaptic currents (IPSCs) are in part provided by striatonigral direct pathway terminals (Grofová and Rinvik, [@B25]; Chevalier et al., [@B15]; Smith and Bolam, [@B54]; Deniau et al., [@B19]; Matuszewich and Yamamoto, [@B39]), which possess functional presynaptic dopamine D~1~-receptors whose activation increases direct pathway inhibition (Porceddu et al., [@B45]; Altar and Hauser, [@B5]; Floran et al., [@B20]; Radnikow and Misgeld, [@B46]; Chuhma et al., [@B16]). Enhancement of direct pathway inhibition facilitates movements while its reduction represses them (Albin et al., [@B3]; Bateup et al., [@B7]; Kravitz et al., [@B35]; Redgrave et al., [@B47]). In contrast, subthalamonigral afferents compose the last step of the indirect pathway (Nakanishi et al., [@B43]; Bevan et al., [@B11]). Presynaptic modulation of subthalamonigral terminals by dopamine uses both classes of dopamine receptors: D~1~ and D~2~ (Ibáñez-Sandoval et al., [@B33]). Activation of D~1~ enhances while activation of D~2~ depresses subthalamonigral excitatory postsynaptic currents (EPSCs). Interestingly, simultaneous blockade of both receptors induced larger evoked EPSCs, suggesting that D~2~-receptors have more influence than D~1~-receptors in the modulation of transmission (Ibáñez-Sandoval et al., [@B33]).

In parallel, the external globus pallidus (GPe) also sends an inhibitory input to SNr (Bevan et al., [@B12]; Kita, [@B34]; Connelly et al., [@B17]). In the present work we investigated dopaminergic presynaptic modulation of inhibitory pallidonigral afferents. We found that D~2~-class receptors regulate these terminals with no sign of D~1~-receptor modulation as compared to striatonigral D~1~-mediated modulation in the same preparation. Interestingly, and as shown before for subthalamonigral afferents (Ibáñez-Sandoval et al., [@B33]), we found that addition of selective receptor antagonists disclose a tonic action of ambient dopamine levels on both, striatonigral and pallidonigral afferents, supporting the notion that dopamine receptors are sensing extracellular dopamine continuously (Yanovsky et al., [@B62]). Furthermore, the blockade of all dopamine receptor types altogether induced a recurrent bursting firing pattern in SNr projection neurons, a mode of firing typically seen in both Parkinsonian humans and animals (e.g., Magill et al., [@B37]; Walters et al., [@B61]; Walters and Bergstrom, [@B60]; Zold et al., [@B64]). This finding indicates that it is enough to acutely block dopamine receptors to induce a Parkinsonian firing pattern in SNr neurons. Given the direct projection of SNr to brain stem nuclei controlling muscular tone and CPGs activation, a question as to whether dopamine dysfunction in the output nuclei is enough to produce some Parkinsonian signs (Morris et al., [@B41]; Hemsley and Crocker, [@B29]; Hikosaka et al., [@B30]; Takakusaki et al., [@B55]) is set forth.

Materials and Methods
=====================

Procedures were carried out in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1996) and were approved by the Institutional Animal Care Committee of UNAM. Methods have been reported elsewhere (Beurrier et al., [@B9]; Ibáñez-Sandoval et al., [@B33]). Briefly, Wistar rats (15--40 postnatal day), were anesthetized with isoflurane, decapitated, and their brains removed. Parasagittal or parahorizontal slices (300 μm) containing the neostriatum (NSt), globus pallidus (GP), and substantia nigra pars reticulata (SNr) were obtained with a vibratome in saline of the following composition (in millimolar): 124 choline chloride, 2.5 KCl, 1.0 MgCl~2~, 1.2 NaH~2~PO~4~, 2.0 CaCl~2~, and 10 glucose (\~4°C 95% O~2~, 5% CO~2~). Whole-cell patch-clamp recordings were performed on rat SNr neurons (Ibáñez-Sandoval et al., [@B33], [@B32]). Neurons within the SNr were visualized with infrared differential interference videomicroscopy using a X60 water--immersion objective. For voltage-clamp recordings micropipettes 2--5 MΩ resistance were filled with internal saline containing high Cl^−^ (in millimolar): 70 KH~2~PO~4~, 36 KCl, 2 MgCl~2~, 10 HEPES, 1.1 EGTA, 0.2 Na~2~ATP, 0.2 Na~3~GTP, 5 mM QX-314, 5 mM CsCl, and 0.1% biocytin (pH 7.2; 275 mOsM/l) that allowed to record inward IPSCs from SNr neurons after field stimulation in the internal capsule (IC) 0.5--1.0 mm outside the SNr border (Radnikow and Misgeld, [@B46]; Wallmichrath and Szabo, [@B59]). Bipolar pencil shaped concentric tungsten electrodes, 11.5 μm at the tip, and 1 kΩ DC resistance were used. For current-clamp recordings we used internal saline of the following composition (in millimolar): 120 KSO~3~CH~4~, 10 NaCl, 10 EGTA, 10 HEPES, 1 CaCl~2~, 2 MgCl~2~, 2 ATP-Mg, 0.3 GTP-Na (pH 7.3, 290 mOsM/l. Superfusion saline contained antagonists for glutamatergic receptors: 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D-(−)-2-amino-5-phosphopentanoic acid (APV) to isolate IPSCs. In parasagittal slices, 3 out of 10 recordings evoked pallidonigral IPSCs and the rest evoked striatonigral IPSCs (Figure [1](#F1){ref-type="fig"}). In parahorizontal slices 6 out of 10 recordings evoked pallidonigral IPSCs and the rest evoked striatonigral IPSCs. IPSCs from each source were easily discernible with electrophysiological techniques (Figure [1](#F1){ref-type="fig"}; Connelly et al., [@B17]) so that when an obvious mixture of IPSCs from both sources was obtained, it was discarded from the present analysis. Holding potential was −80 mV. A paired-pulse protocol was employed with inter-pulse intervals of 50 ms to evaluate changes in the paired-pulse ratio (PPR) of evoked IPSCs (PPR = 2nd IPSC/1st IPSC) to verify presynaptic actions of transmitters (Ibáñez-Sandoval et al., [@B33]). Amplitude of first IPSC was used to build time courses of dopaminergic actions. Because striatonigral fibers pass through the GPe, D~2~-class selective agonists were tested in slices taken from animals with a stereotaxic lesion (ibotenic acid) of the GPe (1.4 mm AP, 3.4 L, and 4.7 mm V) and compared to recordings obtained without a lesion. The lesion further confirmed the differences of IPSCs from both sources. Ibotenic acid solution (dissolved in PBS adjusted to pH 7.4 with NaOH 3.0 μg/0.4 μl) was used to lesion the GPe. These values closely followed Paxinos and Watson ([@B44]) coordinates system.

![**Differences between striatonigral and pallidonigral inhibitory postsynaptic currents**. **(A)** Striatonigral inhibitory postsynaptic currents (IPSCs) exhibited paired-pulse facilitation. **(B)** Pallidonigral IPSCs exhibit paired-pulse depression. **(C)** Short-term synaptic plasticity (STP) from striatonigral afferents is facilitation. **(D)** STP from pallidonigral afferents is depression with numerous failures. **(E)** Intensity--amplitude plots (I--A plots) from striatonigral IPSCs exhibit a sigmoidal shape. **(F)** I--A plots from pallidonigral IPSCs exhibit a jump to maximal amplitude after reaching threshold. I--A plots were fitted to: *A*(*I*) = *A*~max~/(1 + *e*^−*k*(*I*−*Ih*)^) where *A(I) = IPSC* amplitude as a function of stimulus intensity, *A*~max~ = maximal amplitude reached, *k* = slope factor, and *I~h~* = stimulus intensity necessary to reach IPSC amplitude equal to half maximal amplitude. All parameters were significantly different. **(G)** Cluster plot showing that IPSCs from these sources can be separated. PPR = paired-pulse ratio. τ~D~ = decay time constant of IPSCs. *R*~S~ = rise time of IPSCs.](fnsys-05-00006-g001){#F1}

Drugs were stored as dry aliquots and stock solutions were prepared prior to each experiment and added to the perfusion solution in the final concentration indicated. SKF 81297: (±)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide (10 nM--50 μM); SCH 23390: 7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (50 nM and 1 μM); CNQX: 6-cyano-7-nitroquinoxaline-2,3-dione (10 μM), D-AP-5 :D-(−)-2-amino-5-phosphopentanoic acid (50 μM), bicuculline methiodide or methchloride (10 μM), and QX-314 (5 mM inside the recording pipette), all were obtained from Sigma-Aldrich (St. Louis MO, USA). The neurons in the present work were SNr projection neurons (*n* = 250; see: Ibáñez-Sandoval et al., [@B33]). IPSCs parameters from different afferents, i.e., striatonigral and pallidonigral were compared with Mann--Whitney\'s *U*-tests. IPSCs parameters in the same synapses before and after adding a given drug were compared with Wilcoxon\'s *t*-tests. At least 10 min of stable recordings before and after administering the drugs were used to reach stable average IPSCs amplitudes. Each symbol represents mean and SEM of quantal variation in a single representative experiment. Sample averages are given in the text. Differences in parameters of fitted functions were compared by using their estimation error and Student\'s *t-*tests.

Results
=======

Figure [1](#F1){ref-type="fig"} shows that striatonigral and pallidonigral synaptic inputs cannot be confused (Connelly et al., [@B17]). For similar stimulus, evoked striatonigral IPSCs were significantly smaller than pallidonigral IPSCs (mean ± SEM for the first IPSC of a paired response): 235 ± 50 pA (*n* = 32) vs. 1399 ± 152 pA (*n* = 20; *P* \< 0.0001), respectively. Responses to paired-pulse stimulation were also different: striatonigral IPSCs showed paired-pulse facilitation: PPR = 1.41 ± 0.07 (Figures [1](#F1){ref-type="fig"}A,G; *n* = 30) whereas pallidonigral IPSCs always exhibited paired-pulse depression: PPR = 0.4 ± 0.06 (Figures [1](#F1){ref-type="fig"}B,G; *n* = 19; *P* \< 0.0001), although not always as strong as that depicted in Figure [1](#F1){ref-type="fig"}D. Short-term plasticity (10 pulses at 20 Hz) exhibited facilitation without failures in striatonigral connections (Figure [1](#F1){ref-type="fig"}C; *n* = 8), whereas it exhibited depression with intermittent failures in pallidonigral synapses (Figure [1](#F1){ref-type="fig"}D; *n* = 4). The decay time constant/rise time ratio was also different: 4.5 ± 0.5 (*n* = 30) in striatonigral synapses and 12.6 ± 0.8 in pallidonigral synapses (*n* = 19; *P* \< 0.0001) showing that pallidonigral IPSCs are briefer than striatonigral ones (Connelly et al., [@B17]). Intensity--Amplitude (I--A) relationships were also constructed and fitted to a three parameter sigmoidal function (Tecuapetla et al., [@B58]):
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where *A*(*I*) = IPSC amplitude as a function of stimulus intensity, *A*~max~ = maximal amplitude reached, *k* = slope factor, and *I~h~* = stimulus intensity necessary to reach IPSC amplitude equal to half maximal amplitude. All three parameters were significantly different when comparing IPSCs from striatonigral vs. pallidonigral afferents: *A*~max~: 430 ± 3 pA vs. 1512 ± 10 pA (*n* = 8; *P* \< 0.0001); *k* = 3.6 ± 0.3 vs. 14 ± 5 (*n* = 8; *P* \< 0.0001) and *I~h~*: 2.3 ± 0.2 vs. 1.1 ± 0.1 (*n* = 8; *P* \< 0.005).

These features coincide with a previous report (Connelly et al., [@B17]) and were verified qualitatively by evoking IPSCs from either the subthalamic nucleus (NST) or the GPe, however, in these occasions IPSCs were considerably smaller and amplitude could not be compared by itself given the different distances from stimulating and recording electrodes (not shown). Striatonigral IPSCs features have been well described (Radnikow and Misgeld, [@B46]; Wallmichrath and Szabo, [@B59]; Beurrier et al., [@B9]; Chuhma et al., [@B16]) as well as IPSCs from pallidal origin making synapses into the SNr and other nuclei (Tecuapetla et al., [@B58]; Baufreton et al., [@B8]; Connelly et al., [@B17]). Finally, three of these variables were used to build a cluster plot (Figure [1](#F1){ref-type="fig"}G) which confirmed the easiness to separate IPSCs from each source.

The actions of selective dopamine receptor agonists for D~1~- and D~2~-receptor classes were tested. As it has been repeatedly demonstrated, the action of dopaminergic D~1~-class selective agonists at nanomolar concentrations was that of enhancing striatonigral IPSCs (Floran et al., [@B20]; Radnikow and Misgeld, [@B46]; Chuhma et al., [@B16]): striatonigral IPSC increased 153 ± 10% after 300 nM SKF 81297 (*n* = 15; *P* \< 0.001) and the paired-pulse ratio (PPR = IPSC2/IPSC1) decreased from 1.4 ± 0.13 in the control to 1.0 ± 0.12 during SKF 81297 (*P* \< 0.001), confirming a presynaptic modulation. These actions were reversible and blocked by 100 nM of the D~1~-antagonist SCH 23390 (*n* = 5; not shown here but see below) indicating that at these concentrations the action is specific. In addition, here we show that the agonists have no significant action on pallidonigral IPSCs (cf., Figures [2](#F2){ref-type="fig"}A,B).

![**Contrasting actions of D~1~- and D~2~-receptor agonists on striatonigral and pallidonigral IPSCs**. **(A)** 100 nM of the selective D~1~-class receptor agonist, SKF 81297, enhanced striatonigral IPSCs. **(B)** 100 nM SKF 81297, had no action on pallidonigral IPSCs. **(C)** 500 nM of the selective D~2~-class receptor agonist, quinelorane, had no significant action on striatonigral IPSCs. In some cases the GPe was lesioned to better avoid contamination from pallidonigral afferents. **(D)** 500 nM quinelorane greatly reduced pallidonigral IPSCs. Note changes in PPR accompanying significant effects. Record 3 in each frame is the superimposition of records 1 and 2 after normalization of the first IPSC to better appreciate the PPR change when it is present.](fnsys-05-00006-g002){#F2}

Contrasting results were obtained when a selective D~2~-class receptor agonist, 500 nM quinelorane, was employed: striatonigral IPSCs suffered no significant alteration (Figure [2](#F2){ref-type="fig"}C; *n* = 5 NS; Chuhma et al., [@B16]) whereas pallidonigral IPSCs were significantly inhibited (Figure [2](#F2){ref-type="fig"}D) by 73 ± 18% (Figure [2](#F2){ref-type="fig"}D; *n* = 19; *P* \< 0.0001). PPR increased from 0.76 ± 0.1 to 1.83 ± 0.2 (*P* \< 0.001), suggesting a presynaptic action. These actions were reversible and blocked by 500 nM sulpiride, a D~2~-antagonist (*n* = 5; not shown but see below).

Summarizing, physiological action of D~1~-receptor agonists on striatonigral terminals is that of IPSC enhancement as previously shown (Floran et al., [@B20]; Radnikow and Misgeld, [@B46]; Chuhma et al., [@B16]) with no action on pallidonigral terminals. On the other hand, physiological action of D~2~-receptor agonists on pallidonigral IPSCs is that of depression with no significant action on striatonigral terminals.

Therefore we were forced to infer that reports about D~1~-mediated inhibition of striatonigral terminals (Miyazaki and Lacey, [@B40]) were either involving a non-specific action, a pallidal contamination, or both. To test this hypothesis we used larger micromolar concentrations of the D~1~-agonist while evoking IPSCs from both pathways. Figures [3](#F3){ref-type="fig"}A,B show that 5 μM SKF 81297 decreased IPSCs evoked from both set of terminals. Striatonigral IPSC decreased 82 ± 13% (*n* = 18; *P* \< 0.001) and pallidonigral responses decreased by 35 ± 15% (*n* = 6; *P* \< 0.005). These actions could not be blocked by micromolar concentrations of SCH 23390 (not shown), suggesting that they were not specific. In view of these results we built a concentration--response relationship (C--R plot) using a wide range of SKF 81297 concentrations while stimulating striatonigral afferents. This C--R plot can be seen in Figure [3](#F3){ref-type="fig"}C: it is biphasic. When the Hill equation was fitted to the ascending (specific part) EC~50~ was 440 ± 60 nM and the Hill coefficient 1.6 ± 0.2, suggesting cooperativity and a specific action at submicromolar concentrations. Moreover, the fact that pallidonigral inputs are also affected when they do not respond when submicromolar concentrations of agonists are used confirmed non-specific actions.

![**Biphasic concentration--response relationship of D~1~-agonist**. **(A)** 5 μM SKF 81297 decreased IPSCs evoked from striatonigral terminals. **(B)** 5 μM SKF 81297 decreased IPSCs evoked from pallidonigral terminals. Record 3 in each frame is the superimposition of representative records 1 and 2 after normalization of the first IPSC to better appreciate the PPR change when it is present. **(C)** Concentration--response relationship (C--R plot) showed a biphasic response on striatonigral responses: once 3 μM are surpassed, IPSCs decay with increasing concentrations. Ascending C--R plot was fitted with the Hill equation finding a submicromolar EC~50~.](fnsys-05-00006-g003){#F3}

Given the low concentrations of agonists needed to activate D~1~- and D~2~-class receptors in their respective terminals (striatonigral and pallidonigral) we inferred that, perhaps, endogenous extracellular dopamine exerts a tonic action on these receptors. Figure [4](#F4){ref-type="fig"} shows that this hypothesis is correct. Figures [4](#F4){ref-type="fig"}A,B show that 50 nM of a D~1~-class receptor selective antagonist, SCH 23390, are enough to inhibit striatonigral IPSCs with no significative action on pallidonigral IPSC. Striatonigral IPSC decreased from 319 ± 75 in the control to 150 ± 11 pA after 50 nM SCH 23390 (*n* = 12; *P* \< 0.02). Figures [4](#F4){ref-type="fig"}C,D confirm these findings and further show that potency and speediness of D~1~-action is concentration dependent. Striatonigral IPSC is greatly reduced -- almost abolished -- when a low micromolar antagonist concentration is maintained in the superfusion (Figure [4](#F4){ref-type="fig"}C). The effect is reversible (not shown). Traces chosen at different times during the time course, superimposed, and normalized to the amplitude of the first IPSC, show that the PPR is greatly increased from 1.9 ± 0.4 in the control to 2.4 ± 0.6 after SCH 23390 (*n* = 21; *P* \< 0.001; when the IPSC is abolished PPR cannot be measured); confirming a presynaptic site of action. On the other hand, SCH 23390 did not produce any action on pallidonigral IPSC at any concentration (Figure [4](#F4){ref-type="fig"}D). In summary, D~1~-receptors in direct pathway striatonigral terminals are sensitive detectors of extracellular dopamine. Moreover, blockade of dopaminergic action can reduce striatonigral synaptic reliability to a minimum.

![**Presynaptic dopamine receptors sense endogenous extracellular dopamine**. **(A)** 50 nM of selective dopamine D~1~-receptor antagonist, SCH 3390, are enough to reduce striatonigral IPSC amplitude. **(B)** The same antagonist concentration has no action on pallidonigral IPSC. **(C)** Increasing D~1~-antagonist concentration (1 μM) greatly reduced IPSC while speeding up dopamine actions on striatonigral IPSC, suggesting a concentration dependent mechanism. **(D)** The same antagonist concentration has no action on pallidonigral IPSC. **(E)** 500 nM U-9914A, a selective D~3~-type receptor antagonist, significantly enhanced pallidonigral IPSC. Note a partial reversion. **(F)** 500 nM LY750, a selective D~4~-type receptor antagonist, significantly increased pallidonigral IPSC. Record 3 in each frame is the superimposition of representative records 1 and 2 after normalization of the first IPSC to better appreciate the PPR change when it is present.](fnsys-05-00006-g004){#F4}

In addition, Figures [4](#F4){ref-type="fig"}E,F illustrate the actions of selective antagonists for D~3~- and D~4~-type dopamine receptors: 500 nM U-9914A, a selective D~3~-type receptor antagonist enhanced pallidonigral IPSCs by 262 ± 16% after (*n* = 12; *P* \< 0.001) while the PPR decreased from 0.87 ± 0.08 in the control to 0.51 ± 0.1 during the antagonist. On the other hand, 500 nM LY750, a selective D~4~-type receptor antagonist increased pallidonigral IPSCs by 170 ± 20% (*n* = 7; *P* \< 0.001) while PPR decreased from 0.78 ± 0.07 in the control to 0.57 ± 0.09 during the blockade. Sulpiride a generic D~2~-class receptor antagonist had similar actions (not shown): pallidonigral IPSCs increased by 150 ± 14% (*n* = 3) while PPR decreased from 0.77 ± 0.03 in the control to 0.35 ± 0.01 during blockade. To summarize, D~3/4~-receptors in pallidonigral terminals (Murray et al., [@B42]; Bevan et al., [@B12]; Marshall et al., [@B38]; Rivera et al., [@B49]; Seeman et al., [@B51]; Acosta-García et al., [@B2]; Gasca-Martinez et al., [@B22]) are sensitive to extracellular dopamine, which has the role of tonically repressing the force of these synapses. Some functional differences in the actions of these receptor types perhaps deserve further investigation (cf., Figures [4](#F4){ref-type="fig"}E,F).

Finally, because subthalamonigral terminals are also tonically controlled by presynaptic dopamine receptors (D~1~- and D~2~-class; Ibáñez-Sandoval et al., [@B33]) and because blockade of these receptors enhance subthalamonigral EPSCs (Ibáñez-Sandoval et al., [@B33]), we propose the following hypothesis based in the present and previous results (Radnikow and Misgeld, [@B46]; Acosta-García et al., [@B2]; Chuhma et al., [@B16]): that acute blockade of both D~1~- and D~2~-class (including D~3/4~-types) receptors (by 1 μM SCH 23390 plus 1 μM sulpiride) altogether may decrease direct pathway synapses (striatonigral) and, at the same time, enhance indirect pathway synapses (subthalamonigral and pallidonigral), both actions being required in physiopathological models of Parkinsonism to elicit the signs of the disease. The result can be seen in Figure [5](#F5){ref-type="fig"}: SNr neurons shifted from a tonic firing pattern in the control to a bursting firing pattern after blockade of dopamine receptors (*n* = 7 neurons; Ibáñez-Sandoval et al., [@B32]).

![**Blockade of dopamine receptors changes the firing pattern of SNr neurons**. Spontaneous tonic firing was the usual firing pattern recorded in SNr neurons in control conditions (top). During acute blockade of dopamine D~1~- and D~2~-class receptors (1 μM SCH 23390 plus 1 μM sulpiride) SNr firing pattern shifted from tonic to a bursting pattern in *n* = 7 cells; two cells exhibited bursting before adding the blockers. To see whether besides striatonigral and pallidonigral afferents, subthalamonigral afferents were also contributing to this firing mode, the glutamate NMDA-receptor antagonist, 50 μM APV was added to the bath saline (bottom). The firing tended to return to a tonic firing pattern but it was frequently interrupted by sudden hyperpolarizations.](fnsys-05-00006-g005){#F5}

One of the most supported neuronal correlates of Parkinsonism: recurrent bursting in SNr neurons, was similar to that previously reported *in vivo* and *in vitro* (Hammond et al., [@B28]; Ibáñez-Sandoval et al., [@B32]; Walters et al., [@B61]; Walters and Bergstrom, [@B60]; Zold et al., [@B64]). Transitions from tonic to bursting firing mode can rarely be seen spontaneously in control preparations (Ibáñez-Sandoval et al., [@B32]).

To see whether excitatory subthalamonigral afferents, that is, the STN-GP circuit, was participating in this firing behavior, we added the NMDA-receptor antagonist APV (50 μM) to provoke a partial block of STN influence. The result was that the firing pattern became less bursty and more tonic (Ibáñez-Sandoval et al., [@B32]), however, firing was still abruptly interrupted by sudden hyperpolarizations, probably coming from enhanced pallidonigral inputs.

Discussion
==========

The present work shows that extracellular dopamine concentrations are tonically being sensed by the synaptic terminals of inhibitory inputs to the SNr in opposite ways. Thus, blockade of D~1~-type receptors in striatonigral (direct pathway) afferents decreased striatonigral inhibition while blockade of D~3/4~-types receptors in pallidonigral terminals enhanced pallidonigral inhibition. Pallidonigral afferents are presynaptically controlled by D~2~-class but not D~1~-class receptors. Still other inputs to the SNr have to be studied to see whether they are presynaptically modulated.

Striatonigral and pallidonigral IPSCs are different
---------------------------------------------------

Striatonigral IPSCs are smaller but last longer than pallidonigral IPSCs. In addition, they exhibit short-term facilitation and are positively regulated by D~1~-receptors (Floran et al., [@B20]; Radnikow and Misgeld, [@B46]; Connelly et al., [@B17]). Strong evidence for the last property has been obtained with optogenetic techniques (Chuhma et al., [@B16]), supporting the present and previous reports. In comparison, pallidonigral IPSCs are larger and exhibit different degrees of short-term depression (Connelly et al., [@B17]). The two classes of inhibition are so different that cannot be confused. Pallidonigral IPSCs are negatively regulated by D~2~-class receptors and have no D~1~-modulation. Notably, short-term facilitation works as a high pass filter of incoming inputs whereas short-term depression works as a low pass filter (Abbott and Regehr, [@B1]). In contrast, subthalamonigral excitatory synapses are controlled by both D~1~- and D~2~-class receptors (Ibáñez-Sandoval et al., [@B33]).

Selective dopamine receptor agonists exert their specific actions at nanomolar or low micromolar concentrations but higher concentrations become non-specific, thus explaining previous contradictions (cf., Miyazaki and Lacey, [@B40]; Radnikow and Misgeld, [@B46]) and probably similar discrepancies within the striatal/accumbinal circuitry (Guzman et al., [@B26]; Taverna et al., [@B57]). To summarize: D~1~-receptor activation enhances GABA release in terminals from medium spiny neurons of the direct pathway whereas D~3/4~-receptor activation represses GABA release from pallidonigral terminals.

Striatonigral and pallidonigral dopamine receptors sense extracellular ambient endogenous dopamine
--------------------------------------------------------------------------------------------------

Because nanomolar concentrations of selective receptor agonist are needed to modify transmission, we hypothesized that administrations of selective dopamine receptor antagonist would disclose the actions of endogenous dopamine present in the extracellular space. Therefore, to disclose the action of ambient endogenous dopamine we applied selective D~1~- and D~3/4~-receptor antagonists. Our findings were that according to the concentration, suppression of endogenous dopamine action greatly reduced striatonigral transmission while it enhanced pallidonigral transmission. These results indicated that extracellular dopamine concentrations are regulating synaptic release probability in both types of connections, increasing release probability in striatonigral synapses and decreasing release probability in pallidonigral synapses.

Therefore, the following working hypothesis resulted from the present experiments: tonic levels of dopamine in SNr are necessary to maintain the normal function of direct pathway connections and maintain in check indirect pathway synapses from both pallidonigral terminals (present work) and subthalamonigral terminals (Ibáñez-Sandoval et al., [@B32]). The logical functional consequence of this hypothesis was tested: blockade of tonic dopamine action would enhance indirect pathway transmission and reduce direct pathway input thus yielding a previously observed neuronal correlate of Parkinsonism: SNr neurons shifted their tonic firing pattern to a bursting firing pattern typical of subjects with the disease (Takakusaki et al., [@B56]; Rivlin-Etzion et al., [@B50]; Hammond et al., [@B28]; Ibáñez-Sandoval et al., [@B32]; Walters et al., [@B61]; Zold et al., [@B64]).

Tonic spontaneous firing is preserved in the slice preparation in both GPe and STN (e.g., Beurrier et al., [@B10]; Chan et al., [@B14]). Calcium imaging techniques recording dozens of cells simultaneously within the striatal circuit show that there is always some spontaneous activity in striatal spiny neurons in control conditions (Carrillo-Reid et al., [@B13]). Moreover, there is a great amount of convergence between the striatum and the substantia nigra and inhibitory striatonigral events are of large amplitude (e.g., Chuhma et al., [@B16]). Thus, for a SNr neuron there always may be some striatal cell firing. Therefore, the lost balance between direct and indirect pathways by the acute blockade of dopamine receptors is the most probable cause of bursting in SNr neurons during the present experiments.

Postsynaptic dopamine receptors on SNr neurons cannot explain bursting because their function is to increase tonic firing frequency via a cation current; their blockade resulting in lower tonic frequency with irregularities, but not continuous bursting behavior (Lee and Tepper, [@B36]; Zhou et al., [@B63]).

Functional consequences
-----------------------

Because the change in firing pattern of SNr neurons was achieved acutely by blocking dopamine receptors one can speculate what would happen during a chronic absence of dopamine in the output nuclei of the BG. The absence of dopamine (e.g., Parkinsonism) may reduce the function of direct pathway synapses in such a way that maintaining this state of affairs in the long-time would lead to loss of direct pathway synapses due to long-term synaptic plasticity. In contrast, maintaining a high function in pallidonigral and subthalamonigral synapses would produce long-term potentiation of these synapses. These events taken together may tend to change the circuitry permanently, making not only L-DOPA inefficient but, perhaps, making the chronic diseased circuitry radically different than the control or healthy circuit: that is, more dependent on the subthalamopallidal loop (Magill et al., [@B37]; Baufreton et al., [@B8]).

Bursting in SNr neurons leads to tremor and rigidity (Hemsley and Crocker, [@B29]; Takakusaki et al., [@B56]). Moreover, this configuration of synaptic weights would lead to the loss of high pass filtering of SNr inputs (direct pathway\'s short-term facilitation) and an increase in low pass filtering of SNr inputs (pallidonigral short-term depression; Abbott and Regehr, [@B1]) setting the stage to favor the entrance to an akinetic frequency lock (Hutchison et al., [@B31]; Avila et al., [@B6]). Consequently, therapeutic ways of activating the direct pathway in the chronic patient may be fundamental to avoid irreversible plastic changes in the network (Hammond et al., [@B28]; Walters et al., [@B61]; Walters and Bergstrom, [@B60]; Zold et al., [@B64]; Bateup et al., [@B7]; Kravitz et al., [@B35]).
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